Acute Therapies at Baxter - Global

Randomized controlled trials have reported a high incidence of hypophosphatemia and hypokalemia in patients with AKI receiving renal replacement therapy, with hypophosphatemia occurring in up to 60% of patients.[1,2] Baxter’s phosphate-containing dialysis and replacement solutions are designed to reduce the incidence of hypophosphatemia and the need for phosphate supplementation during CRRT.[3-8] Learn how Baxter’s portfolio of phosphate formulations enables individualized treatment to help meet a patient’s specific clinical needs as part of the hospital protocol. https://ow.ly/4uku50SBru5 AKI – acute kidney injury; CRRT – continuous renal replacement therapy; RRT – renal replacement therapy For safe and proper use of the products mentioned herein, please refer to the Operator's Manual or Instructions for Use. References: 1. Bellomo R, et al. N Engl J Med. 2009;361(17):1627-1638. 2. Palevsky PM, et al. N Engl J Med. 2008;359(1):7-21. 3. Thompson Bastin M, et al. Blood Purif. 2022;51:122-129. 4. Crowley K, et al. Hemodial Int. 2020 Jul; 24(3):330-334. 5. Broman M, et al. Acta Anaesthesiol Scand. 2011;55:39-45. 6. Besnard N, et al. Blood Purif. 2016;42(1):18-26. 7. Morabito S, et al. BMC Nephrol. 2013;14:232. 8. Chua H, et al. Blood Purif. 2012;34: 306-312. #CRRT #AcuteTherapies #VitalOrganTherapies #AKI #CRRTSolutions #AcidBaseDisorders #PrisMax #MetabolicAcidosis

Baxter bicarbonate-buffered solutions for CRRT, with various concentrations of electrolytes, help normalize electrolyte and acid-base disorders such as hyperkalemia, metabolic acidosis, hypocalcemia and hyperphosphatemia that can be associated with acute kidney injury (AKI).¹⁻⁴ Learn how Baxter’s portfolio of bicarbonate formulations enables individualized treatment to help meet a patient’s specific clinical needs as part of the hospital protocol. https://ow.ly/OGWx50Szg53 AKI, acute kidney injury; CRRT, continuous renal replacement therapy For safe and proper use of the products mentioned herein, please refer to the Operator's Manual or Instructions for Use. References: 1. Claure-Del Granado R, et al. Blood Purif. 2012;34:186-193. 2. Biphozyl SmPC 2018-06. 3. Phoxilium 1.2 mmol/L phosphate SmPC 2023-03. 4. Hemosol B0 Package Leaflet 2018. #CRRT #AcuteTherapies #VitalOrganTherapies #AKI #CRRTSolutions #AcidBaseDisorders #PrisMax #MetabolicAcidosis

Baxter bicarbonate-buffered solutions for CRRT, with various concentrations of electrolytes, help normalize electrolyte and acid-base disorders such as hyperkalemia, metabolic acidosis, hypocalcemia and hyperphosphatemia that can be associated with acute kidney injury (AKI).¹⁻⁴ Learn how Baxter’s portfolio of bicarbonate formulations enables individualized treatment to help meet a patient’s specific clinical needs as part of the hospital protocol. https://ow.ly/eS1850RTlnR AKI, acute kidney injury; CRRT, continuous renal replacement therapy For safe and proper use of the products mentioned herein, please refer to the Operator's Manual or Instructions for Use. References: 1. Claure-Del Granado R, et al. Blood Purif. 2012;34:186-193. 2. Biphozyl SmPC 2018-06. 3. Phoxilium 1.2 mmol/L phosphate SmPC 2023-03. 4. Hemosol B0 Package Leaflet 2018. #CRRT #AcuteTherapies #VitalOrganTherapies #AKI #CRRTSolutions #AcidBaseDisorders #PrisMax #MetabolicAcidosis

Watch Dr. Wiis, Intensivist, discuss how any technology supporting CRRT delivery should improve staff efficiency while improving patient care and costs. Baxter’s 𝗧𝗿𝘂𝗲𝗩𝘂𝗲 digital health solutions help you optimize CRRT therapy delivery by providing opportunities to improve productivity and efficiency. 𝗧𝗥𝗨𝗘𝗩𝗨𝗘 𝗖𝗢𝗡𝗡𝗘𝗖𝗧 allows your 𝗣𝗿𝗶𝘀𝗠𝗮𝘅 system to wirelessly and securely connect to the EMR, enabling your CRRT staff to spend less time on documentation and helping them to refocus time on direct patient care. 𝗧𝗥𝗨𝗘𝗩𝗨𝗘 𝗧𝗛𝗘𝗥𝗔𝗣𝗬 𝗠𝗔𝗡𝗔𝗚𝗘𝗠𝗘𝗡𝗧 enhances your Baxter partnership with ongoing consultations dedicated to analyzing key CRRT program metrics to help reduce costs and improve workflow efficiencies. Learn more today: https://ow.ly/cLkP50Rpf0o. For safe and proper use of the products mentioned herein, please refer to the Operator’s Manual or Instructions for Use. CE 0123 Baxter, PrisMax, and TrueVue are registered trademarks of Baxter International Inc. or its subsidiaries. GBU-AT27-230040 (v1.0) 03/2024 #AcuteTherapies #TrueVue #CRRT #CriticalCare #ICU #Baxter #QualityImprovements

Join us at the 2024 ECOS-TCS National Congress in Paris for a Baxter sponsored symposium: “Extracorporeal Organ Support – What’s New? What is its Potential in Precision Medicine”. Tuesday June 25, 2024 12:30 - 13:30 UICP, Stephenson Room 16 rue Jean Rey, 75015 Paris, France Learn More: https://ow.ly/EEU450SmSPF #ECOSTCS24 #Baxter #AcuteTherapies #OrganSupportTherapies #BloodPurification

Why use ECCO2R in patients with acute respiratory distress syndrome (ARDS)? Watch this 1-minute highlight from ISICEM 2024 in which Professor Alain Combes discusses potential benefits of ECCO2R, including decreased ventilator-induced lung injury. To learn more, watch the full symposium "Advancing What's Possible in Critical Care": https://ow.ly/TeCo50RTlrj ISICEM 2024 = 43rd International Symposium on Intensive Care & Emergency Medicine in Brussels, Belgium on March 19-22, 2024. Baxter is a trademark of Baxter International Inc. GBU-AT00-240011 (v2.0) 05/2024 #AcuteTherapies #OrganSupportTherapies #Baxter #CriticalCare #ISICEM2024 #ECCO2R

Are you attending 42nd Vicenza Course AKI-CRRT-ECOS? Join us for a discussion on innovations in Acute Kidney Injury and Vital Organ Support. We will be delighted to welcome you to our stand. For Healthcare Professionals only. #ICU #VicenzaCourse #AKI #CRRT #BloodPurification

Join us on June 12 in Room Giotto for our Scientific Symposium: Targeting precision medicine in the critically ill at the 42nd Vicenza Course AKI-CRRT-ECOS (Italy). Rinaldo Bellomo (Australia) will share his insights on RRT practice variations, Gianluca Villa (Italy) will discuss the topic of identifying clinical clusters for blood purification, and Vincenzo Cantaluppi (Italy) will lead the discussion with the clinical experts. Looking forward to seeing you there! For Healthcare Professionals. #VicenzaCourse #ICU #AKI #CRRT #BloodPurification

Recent research with blood purification using the Oxiris filter set suggests a benefit in preventing cardiac surgery-associated acute kidney injury (CS-AKI). Professor Xosé Pérez-Fernández discusses these blood purification findings in this 1-minute highlight from ISICEM 2024. To learn more, watch the full symposium "Advancing What's Possible in Critical Care": https://ow.ly/taoJ50RyYww. ISICEM 2024 = 43rd International Symposium on Intensive Care & Emergency Medicine in Brussels, Belgium on March 19-22, 2024. For safe and proper use of the products mentioned herein, please refer to the Operator's Manual or Instructions for Use. Baxter and Oxiris are trademarks of Baxter International Inc. or its subsidiaries. GBU-AT11-240001 (v2.0) 05/2024 #AcuteTherapies #OrganSupportTherapies #Baxter #CriticalCare #ISICEM2024 #Oxiris #AKI #BloodPurification

Explore the KDIGO podcast series with Dr. Marlies Osterman and guests discussing best practices for fluid, hemodynamic, and drug/nutrition management during kidney replacement therapy. Baxter is pleased to sponsor these Conversations in Nephrology: 𝗘𝗽𝗶𝘀𝗼𝗱𝗲 𝟳: 𝗗𝗿. 𝗝𝗮𝘃𝗶𝗲𝗿 𝗡𝗲𝘆𝗿𝗮 - Best Practices in Fluid Management During CKRT - What is the impact of fluid overload during critical illness? - What is the role of KRT in managing fluid overload? - What are the challenges in removing fluid effectively and safely with KRT? 𝗘𝗽𝗶𝘀𝗼𝗱𝗲 𝟴: 𝗣𝗿𝗼𝗳. 𝗥𝗶𝗻𝗮𝗹𝗱𝗼 𝗕𝗲𝗹𝗹𝗼𝗺𝗼 - The Role of Hemodynamics for AKI and Maintaining Hemodynamic Stability in KRT Patients - Why is hemodynamic stabilization important to protect kidney function? - What are the hemodynamic targets to prevent development or progression of AKI? - If drugs are needed, which drugs would you recommend? 𝗘𝗽𝗶𝘀𝗼𝗱𝗲 𝟵: 𝗗𝗿. 𝗦𝗮𝗻𝗱𝘆 𝗞𝗮𝗻𝗲-𝗚𝗶𝗹𝗹 - Best Practices in Nutrition, Drug Management, and Multi-Organ Support in Patients with AKI - Why are critically ill patients at risk of drug induced AKI? - Does the energy requirement differ for AKI patients receiving RRT? - Is there a role for micronutrient supplementation in patients with AKI? Click here for the new KDIGO podcasts: https://anchor.fm/kdigo. #Baxter #AcuteTherapies #CriticalCare